Strategy changes in Chinese hematologists' diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009-2018)

Chin Med J (Engl). 2019 Nov 20;132(22):2749-2750. doi: 10.1097/CM9.0000000000000511.

Authors

Hong-Hui Wang¹, Hui Bi², Lei Zhang³, Hui-Yuan Li³, Feng Xue³, Ze-Ping Zhou², Ren-Chi Yang³

Affiliations

¹ The Second Clinical College, Kunming Medical University, Kunming, Yunnan 650000, China.
² Department of Hematology, the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China.
³ State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

No abstract available

MeSH terms

China / epidemiology
Hematologic Diseases / diagnosis*
Hematologic Diseases / epidemiology
Humans
Purpura, Thrombocytopenic, Idiopathic / diagnosis*
Purpura, Thrombocytopenic, Idiopathic / epidemiology